4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-4.06%
↑ 85% above average
Average (30q)
-26.85%
Historical baseline
Range
High:65.37%
Low:-278.37%
Volatility
-1280.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -4.06% |
| Q2 2025 | -13.94% |
| Q1 2025 | 3.42% |
| Q4 2024 | -13.29% |
| Q3 2024 | -25.43% |
| Q2 2024 | -7.88% |
| Q1 2024 | -0.37% |
| Q4 2023 | -214.77% |
| Q3 2023 | 65.37% |
| Q2 2023 | -3.26% |
| Q1 2023 | -4.76% |
| Q4 2022 | -6.57% |
| Q3 2022 | 8.53% |
| Q2 2022 | -6.64% |
| Q1 2022 | -5.00% |
| Q4 2021 | -12.79% |
| Q3 2021 | -193.04% |
| Q2 2021 | 53.74% |
| Q1 2021 | 20.15% |
| Q4 2020 | -162.31% |
| Q3 2020 | 48.31% |
| Q2 2020 | -15.14% |
| Q1 2020 | 18.34% |
| Q4 2019 | 3.36% |
| Q3 2019 | -101.93% |
| Q2 2019 | 0.00% |
| Q1 2019 | -278.37% |
| Q4 2018 | 0.00% |
| Q3 2018 | 15.83% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |